CS277650B6 - Combination preparation with anti-thrombotic effect - Google Patents
Combination preparation with anti-thrombotic effect Download PDFInfo
- Publication number
- CS277650B6 CS277650B6 CS904726A CS472690A CS277650B6 CS 277650 B6 CS277650 B6 CS 277650B6 CS 904726 A CS904726 A CS 904726A CS 472690 A CS472690 A CS 472690A CS 277650 B6 CS277650 B6 CS 277650B6
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- acetylsalicylic acid
- kas
- platelet
- carbacycline
- significant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3933027A DE3933027A1 (de) | 1989-09-29 | 1989-09-29 | Kombinationspraeparat mit antithrombotischer wirkung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CS472690A3 CS472690A3 (en) | 1992-08-12 |
| CS277650B6 true CS277650B6 (en) | 1993-03-17 |
Family
ID=6390758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS904726A CS277650B6 (en) | 1989-09-29 | 1990-09-28 | Combination preparation with anti-thrombotic effect |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5093325A (no) |
| EP (1) | EP0420368B1 (no) |
| JP (1) | JP3040463B2 (no) |
| AT (1) | ATE92325T1 (no) |
| CA (1) | CA2069296C (no) |
| CS (1) | CS277650B6 (no) |
| DD (1) | DD299153A5 (no) |
| DE (2) | DE3933027A1 (no) |
| DK (1) | DK0420368T3 (no) |
| ES (1) | ES2058771T3 (no) |
| HU (1) | HUT60140A (no) |
| IE (1) | IE903503A1 (no) |
| IL (1) | IL95849A (no) |
| NO (1) | NO921223L (no) |
| NZ (1) | NZ235521A (no) |
| PT (1) | PT95456B (no) |
| RU (1) | RU2097039C1 (no) |
| WO (1) | WO1991004740A1 (no) |
| ZA (1) | ZA907808B (no) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040180865A1 (en) * | 1993-06-04 | 2004-09-16 | Jeffry W. Kreamer | Aspirin and vitamin and/or trace element compositions for the amelioration and treatment of vascular disease |
| US5830837A (en) * | 1994-11-22 | 1998-11-03 | Novo Nordisk A/S | Amylase variants |
| US5709541A (en) * | 1995-06-26 | 1998-01-20 | Selas Corporation Of America | Method and apparatus for reducing NOx emissions in a gas burner |
| US6010911A (en) * | 1997-04-30 | 2000-01-04 | Medtronic, Inc. | Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique |
| US20060171945A1 (en) * | 2003-02-14 | 2006-08-03 | Critchley Hilary Octavia D | Ip receptor antagonists for the treatment of pathological uterine conditions |
| WO2005116623A2 (en) * | 2004-05-17 | 2005-12-08 | Medtronic, Inc. | Point of care heparin determination system |
| JP2009529057A (ja) * | 2006-03-08 | 2009-08-13 | コートリア・コーポレーシヨン | Ｃｏｘ−関連胃損傷を予防するための非−選択的ｃｏｘ阻害剤との組み合わせ療法 |
| US20130040898A1 (en) * | 2010-04-29 | 2013-02-14 | Pär Johansson | Methods of treatment of patients at increased risk of development of ischemic events and compounds hereof |
| US9345678B2 (en) * | 2013-03-13 | 2016-05-24 | Allergan, Inc. | Prostanoid receptor agonist compounds and methods of use for same |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3524051A1 (de) * | 1985-07-05 | 1987-01-15 | Hoechst Ag | Kombinationspraeparate aus hemmstoffen der thrombozytenaggregation und deren verwendung |
-
1989
- 1989-09-29 DE DE3933027A patent/DE3933027A1/de not_active Withdrawn
-
1990
- 1990-09-28 ZA ZA907808A patent/ZA907808B/xx unknown
- 1990-09-28 CS CS904726A patent/CS277650B6/cs not_active IP Right Cessation
- 1990-09-28 PT PT95456A patent/PT95456B/pt not_active IP Right Cessation
- 1990-09-28 IL IL9584990A patent/IL95849A/en not_active IP Right Cessation
- 1990-10-01 RU SU5011616/14A patent/RU2097039C1/ru not_active IP Right Cessation
- 1990-10-01 HU HU9201045A patent/HUT60140A/hu not_active IP Right Cessation
- 1990-10-01 CA CA002069296A patent/CA2069296C/en not_active Expired - Fee Related
- 1990-10-01 NZ NZ235521A patent/NZ235521A/xx unknown
- 1990-10-01 AT AT90250248T patent/ATE92325T1/de not_active IP Right Cessation
- 1990-10-01 ES ES90250248T patent/ES2058771T3/es not_active Expired - Lifetime
- 1990-10-01 IE IE350390A patent/IE903503A1/en not_active IP Right Cessation
- 1990-10-01 DD DD90344337A patent/DD299153A5/de not_active IP Right Cessation
- 1990-10-01 US US07/591,108 patent/US5093325A/en not_active Expired - Fee Related
- 1990-10-01 EP EP90250248A patent/EP0420368B1/de not_active Expired - Lifetime
- 1990-10-01 WO PCT/DE1990/000750 patent/WO1991004740A1/de active Application Filing
- 1990-10-01 DE DE9090250248T patent/DE59002185D1/de not_active Expired - Lifetime
- 1990-10-01 DK DK90250248.3T patent/DK0420368T3/da active
- 1990-10-01 JP JP2513226A patent/JP3040463B2/ja not_active Expired - Fee Related
-
1992
- 1992-03-27 NO NO92921223A patent/NO921223L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP3040463B2 (ja) | 2000-05-15 |
| IL95849A0 (en) | 1991-06-30 |
| HU9201045D0 (en) | 1992-06-29 |
| ZA907808B (en) | 1992-01-29 |
| IE903503A1 (en) | 1991-04-10 |
| NZ235521A (en) | 1993-03-26 |
| DK0420368T3 (da) | 1993-11-15 |
| CA2069296C (en) | 2002-04-23 |
| PT95456B (pt) | 1997-07-31 |
| US5093325A (en) | 1992-03-03 |
| DE59002185D1 (de) | 1993-09-09 |
| AU640692B2 (en) | 1993-09-02 |
| CA2069296A1 (en) | 1991-03-30 |
| NO921223D0 (no) | 1992-03-27 |
| AU6419090A (en) | 1991-04-28 |
| DD299153A5 (de) | 1992-04-02 |
| HUT60140A (en) | 1992-08-28 |
| ES2058771T3 (es) | 1994-11-01 |
| NO921223L (no) | 1992-03-27 |
| EP0420368B1 (de) | 1993-08-04 |
| DE3933027A1 (de) | 1991-04-11 |
| WO1991004740A1 (de) | 1991-04-18 |
| CS472690A3 (en) | 1992-08-12 |
| IL95849A (en) | 1995-03-30 |
| PT95456A (pt) | 1991-08-14 |
| JPH05500805A (ja) | 1993-02-18 |
| RU2097039C1 (ru) | 1997-11-27 |
| ATE92325T1 (de) | 1993-08-15 |
| EP0420368A1 (de) | 1991-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4451454A (en) | Prophylaxis and treatment of thromboembolic disorders in man and in warm-blooded animals with bicarbonate salts of alkali metals | |
| US6855734B2 (en) | Glycine betaine and its use | |
| US5576304A (en) | Antithrombotic composition | |
| AU754405B2 (en) | A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug | |
| Küster et al. | Platelet aggregation and thromboxane release induced by arachidonic acid, collagen, ADP and platelet-activating factor following low dose acetylsalicylic acid in man | |
| CZ446099A3 (cs) | Použití inhibitoru faktoru Xa, samotného nebo v kombinaci s činidlem proti shlukování krevních destiček a farmaceutické prostředky, které obsahují tyto složky | |
| CS277650B6 (en) | Combination preparation with anti-thrombotic effect | |
| NZ518904A (en) | A pharmaceutical composition comprising a P2T receptor antagonist, or a pharmaceutically acceptable salt thereof, and an anti-thrombotic agent, and the use of the combination in the treatment and prevention of thrombosis | |
| US4510135A (en) | Orally administered heparin | |
| CN103908460B (zh) | 三七皂苷Fc的医药用途 | |
| Neubauer et al. | Inhibitory effect of warfarin on the metastasis of the PAIII prostatic adenocarcinoma in the rat | |
| Shirakura et al. | Antithrombotic effects of KW-3635, a thromboxane A2-receptor antagonist, in guinea pigs | |
| Ito et al. | Role of activated platelets in endotoxin-induced DIC in rats | |
| JPH07507769A (ja) | Ｘ因子のグリコシル化媒介による阻害 | |
| Vlădăreanu et al. | Factor XI and coagulation. Factor XI inhibitors-antithrombotic perspectives | |
| US4400397A (en) | Antithrombotic treatment with quaternary ammonium sulfites and bisulfites | |
| US3721738A (en) | Treatment and prophylaxis of thrombovascular diseases with 2-imidazolone derivatives | |
| Keraly et al. | Specific desensitization of washed rabbit platelets by PAF-acether and derivatives | |
| Østerud et al. | Effect of steroids during Escherichia coli endotoxinaemia in rabbits | |
| KR19980701225A (ko) | 혈전용해약(thrombolytic agent) | |
| HUT77739A (hu) | Orálisan adagolható, dihidro-imidazol-származékot tartalmazó trombolitikus szer | |
| Levi et al. | Hemostasis and | |
| Sandberg et al. | The Appearance Of PF1 And PF3 In Activated Human Platelets | |
| Bergqvist et al. | Platelet-Influencing Agents | |
| Vargaftig et al. | Interference Of Sulphynpyrazone With The Platelet And Bronchial Effects Of “Platelet-Activating Factor” |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| IF00 | In force as of 2000-06-30 in czech republic | ||
| MM4A | Patent lapsed due to non-payment of fee |
Effective date: 20030928 |